Cromos Pharma

Cromos Pharma Cromos Pharma is an international research organization (CRO) specializing in clinical trials. Find out more by visiting www.cromospharma.com.

Established in 2004, Cromos Pharma provides tailored and effective clinical trial services to support the development of drugs that transform healthcare. It is an international CRO with over 15 years' experience in offering fully integrated services and delivering all aspects of clinical trials in all clinical phases and a range of therapeutic areas. Cromos Pharma delivers rapid recruitment and excellent patient retention as well as expert study design and management. Cromos Pharma has strong regional experience in Central and Eastern Europe. Its US base is in Portland, Oregon with additional operations in South Florida and its European HQ is situated in Dublin, Ireland.

12/12/2025

As Hanukkah approaches, we extend warm wishes to our clients, partners, colleagues, and friends who celebrate this meaningful holiday. May these eight days be filled with light, joy, and moments shared with those who matter most.

Wishing you a happy and blessed Hanukkah.

In the latest edition of Cromos Pharma’s Newsletter, we spotlight key breakthroughs shaping clinical research:– Alzheime...
12/12/2025

In the latest edition of Cromos Pharma’s Newsletter, we spotlight key breakthroughs shaping clinical research:

– Alzheimer’s Care Advances: Blood tests, AI tools, and next-gen therapies enable earlier, more personalized intervention.
– FDA Tightens Elevidys Use: Boxed warning issued after fatal liver complications in non-ambulatory DMD patients.
– mRNA Cancer Vaccines Accelerate: Emerging data show strong signals across multiple tumors, advancing precision immunotherapy.

Read the full December Newsletter here: https://cromospharma.com/clinical-research-focus-47th-edition/

12/02/2025

Cromos Pharma is currently seeking a Project Manager to join our team.

Location: Europe

For additional details about this exciting opportunity, please visit our website: https://cromospharma.com/project-manager/

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

11/26/2025

Happy Thanksgiving!

On this day of gratitude, Cromos Pharma extends warm appreciation to our dedicated team, trusted partners, valued clients, and dear friends.

May your Thanksgiving be filled with light, joy, and meaningful moments as we honor the relationships and shared achievements that inspire our work every day!

11/25/2025

Cromos Pharma is currently seeking an In-House CRA to join our team.

Location: Hungary

For additional details about this exciting opportunity, please visit our website: https://cromospharma.com/in-house-cra/

If you're ready to take the next step in your career with Cromos Pharma, kindly send your CV to cv@cromospharma.com

mRNA cancer vaccines are quickly moving from bold scientific promise to real-world clinical impact. With strong data eme...
11/24/2025

mRNA cancer vaccines are quickly moving from bold scientific promise to real-world clinical impact. With strong data emerging in melanoma, NSCLC, pancreatic cancer, and other hard-to-treat tumors, this platform is shaping up to be one of the biggest oncology breakthroughs of the decade.
In our new article, we look at how mRNA vaccines actually work, why they pair so powerfully with checkpoint inhibitors, and which trials could set the stage for the first approvals as early as 2026–2027.

To learn more, read the full article: https://cromospharma.com/cancer-vaccines-2025-part-i-the-mrna-revolution/

FSP partnerships are reshaping how clinical trials are run. As studies become more complex and data-intensive, the Funct...
11/20/2025

FSP partnerships are reshaping how clinical trials are run. As studies become more complex and data-intensive, the Functional Service Provider model gives sponsors the control, flexibility, and scalability needed to accelerate timelines while maintaining full ownership of data.

Discover why FSP is emerging as the operating model of the future:https://cromospharma.com/fsp-model-in-clinical-trials-everything-sponsors-need-to-know/

We’re excited to share a proud moment from our Bulgaria team! Our Senior Clinical Research Associate, Tihomira Leteyski,...
11/17/2025

We’re excited to share a proud moment from our Bulgaria team!

Our Senior Clinical Research Associate, Tihomira Leteyski, recently organized and hosted an inspiring networking event, “From Burnout to Breakthrough,” bringing together clinical research professionals for an open, honest, and highly relevant conversation about resilience, workload challenges, motivation, and long-term sustainability in our industry.

The session featured a powerful keynote from Kamen Doxev, MD, EMBA, whose insights helped ignite a dynamic exchange of real-world perspectives and practical strategies for thriving in the demanding world of clinical trials.

At Cromos Pharma, we believe that meaningful dialogue and strong professional connections are essential to driving progress. We’re incredibly proud to see our colleagues taking the lead in creating spaces that support growth, collaboration, and community.

Kudos to Tihomira and to all who joined this important conversation!

h

Alzheimer’s research is entering its most transformative decade yet. From blood-based diagnostics and AI prediction mode...
11/13/2025

Alzheimer’s research is entering its most transformative decade yet. From blood-based diagnostics and AI prediction models to multi-pathway therapies and next-gen neural implants — the field is evolving far beyond the amyloid era.

In our new article, we break down five breakthroughs reshaping Alzheimer’s care in 2025 and what they mean for early detection, treatment innovation, and patient outcomes.

Read more: https://cromospharma.com/five-insights-changing-alzheimer-s-care-in-2025/

In the November edition of Cromos Pharma’s Newsletter, we spotlight key breakthroughs shaping clinical research:– ESMO 2...
11/13/2025

In the November edition of Cromos Pharma’s Newsletter, we spotlight key breakthroughs shaping clinical research:

– ESMO 2025 Highlights: Vlad Bogin, MD, FACP, shares what will truly change oncology in 2026.
– FDA National Priority Vouchers: A new program to fast-track therapies for critical diseases.
– Regulatory Affairs Insight: How Cromos Pharma bridges FDA, EMA, and CTIS frameworks for faster, compliant approvals.

Read the full November Newsletter here: https://cromospharma.com/clinical-research-focus-46th-edition/

11/06/2025

We are pleased to share that Nicole Brenna, US Business Development Director at Cromos Pharma, will be attending the 67th ASH Annual Meeting and Exposition, taking place December 6–9, 2025, in Orlando, FL.

Recognized as the world’s largest and most influential event in classical and malignant hematology, ASH 2025 will bring together thousands of leading clinicians, researchers, and industry experts to showcase breakthroughs in blood disorder research, clinical practice, and emerging therapies.

Nicole looks forward to connecting with peers, exploring new partnership opportunities, and discussing how Cromos Pharma supports sponsors in advancing hematology research.

If you would like to schedule a meeting with Nicole during the event, please contact us at inquiry@cromospharma.com.

Address

US Bancorp Tower, 111 S. W. Fifth Avenue, Suite 3150
Portland, OR
97204

Telephone

+15034443463

Website

Alerts

Be the first to know and let us send you an email when Cromos Pharma posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram